A Seer‐Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.70111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Sameh Hany Emile und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, Florida. Hauptthemen laut MEDLINE: Adenocarcinoma, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
We assessed predictors of overall (OS) and cancer‐specific survival (CSS) in stage I colorectal cancer (CRC).
Methods
Retrospective analysis of patients with stage I colon or rectal adenocarcinomas from the SEER database (2010–2020) Survival was assessed using Kaplan‐Meier statistics and multivariable Cox regression analyses. The primary outcomes were 5‐year OS and CSS.
Results
40,001 patients (51.3% male; mean age: 65.1 ± 12.6 years) were included. Colon and rectal cancers accounted for 75.8% and 24.2%, respectively. Five‐year OS and CSS were 83.1% (95% CI: 82.6–83.5%) and 93.2% (95% CI: 92.9–93.5%), respectively. Factors independently associated with worse OS were age (HR: 1.07; p < 0.001), male sex (HR:1.48; p < 0.001), Black race (HR: 1.25; p < 0.001), single, divorced, or widowed status (HR: 1.49, 1.46, and 1.43; p < 0.001), tumor size (HR: 1.001; p = 0.008), poorly differentiated carcinomas (HR: 1.32; p < 0.001), undifferentiated carcinomas (HR:1.44; p = 0.026), perineural invasion (HR: 1.84; p < 0.001), elevated CEA levels (HR: 1.68; p < 0.001), and systemic therapy (neoadjuvant: HR: 1.3; p = 0.032, adjuvant: HR: 2.2; p < 0.001, both: HR: 1.97; p < 0.001). Factors independently associated with worse CSS were age (HR: 1.05; p < 0.001), male sex (HR: 1.32; p < 0.001), Black race (HR: 1.43; p < 0.001), marital status (HR: 1.44, 1.28, and 1.68; p < 0.001), tumor size (HR: 1.003; p < 0.001), poorly differentiated carcinomas (HR: 1.77; p < 0.001), perineural invasion (HR: 2.29; p < 0.001), elevated CEA levels (HR: 2.24; p < 0.001), and systemic therapy (neoadjuvant: HR: 2.53; p = 0.032, adjuvant: HR: 4.22; p < 0.001, both: HR: 3.83; p < 0.001).
Conclusions
Although patients with stage I CRC had excellent survival, single, older, Black, male patients with large, high‐grade tumors associated with perineural invasion and elevated CEA levels had a higher mortality risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, Florida.
- Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt.
- Department of Surgery and Transplantations, Sheba Medical Center, Ramat Gan, Israel, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Sameh Hany Emile, Steven D Wexner
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Emile, S. H., Horesh, N., Garoufalia, Z., Oosenbrug, M., Boutros, M., & Wexner, S. D. (2025). A Seer‐Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70111
Vancouver
Emile SH, Horesh N, Garoufalia Z, Oosenbrug M, Boutros M, Wexner SD. A Seer‐Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70111
BibTeX
@article{Emile2025,
author = {Emile, Sameh Hany and Horesh, Nir and Garoufalia, Zoe and Oosenbrug, Marcus and Boutros, Marylise and Wexner, Steven D},
title = {A Seer‐Based Analysis of Survival Predictors in Stage I Colorectal Adenocarcinomas},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.70111}
}
EUVIMED